138 related articles for article (PubMed ID: 11167146)
1. Expression of heparanase in oral cancer cell lines and oral cancer tissues.
Ikuta M; Podyma KA; Maruyama K; Enomoto S; Yanagishita M
Oral Oncol; 2001 Feb; 37(2):177-84. PubMed ID: 11167146
[TBL] [Abstract][Full Text] [Related]
2. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts.
Kurokawa H; Katsube K; Podyma KA; Ikuta M; Iseki H; Nakajima M; Akashi T; Omura K; Takagi M; Yanagishita M
Cancer Sci; 2003 Mar; 94(3):277-85. PubMed ID: 12824922
[TBL] [Abstract][Full Text] [Related]
3. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of heparanase expression and cellular localization in oral cancer.
Leiser Y; Abu-El-Naaj I; Sabo E; Akrish S; Ilan N; Ben-Izhak O; Peled M; Vlodavsky I
Head Neck; 2011 Jun; 33(6):871-7. PubMed ID: 20859999
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
7. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
Kodama J; Shinyo Y; Hasengaowa ; Kusumoto T; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Oncol Rep; 2005 Jul; 14(1):89-92. PubMed ID: 15944773
[TBL] [Abstract][Full Text] [Related]
8. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728
[TBL] [Abstract][Full Text] [Related]
10. Molecular properties and involvement of heparanase in cancer progression and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Metzger S; Chajek-Shaul T; Atzmon R; Guatta-Rangini Z; Friedmann Y
Biochimie; 2001 Aug; 83(8):831-9. PubMed ID: 11530216
[TBL] [Abstract][Full Text] [Related]
11. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
12. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
[TBL] [Abstract][Full Text] [Related]
13. Human heparanase nuclear localization and enzymatic activity.
Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
[TBL] [Abstract][Full Text] [Related]
14. Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma.
Nagatsuka H; Siar CH; Tsujigiwa H; Naomoto Y; Han PP; Gunduz M; Sugahara T; Sasaki A; Nakajima M
Ann Diagn Pathol; 2012 Oct; 16(5):354-61. PubMed ID: 22575501
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression in clinical digestive malignancies.
Inoue H; Mimori K; Utsunomiya T; Sadanaga N; Barnard GF; Ueo H; Mori M
Oncol Rep; 2001; 8(3):539-42. PubMed ID: 11295076
[TBL] [Abstract][Full Text] [Related]
16. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
[TBL] [Abstract][Full Text] [Related]
17. Heparanase, a potential marker for premalignant oral cavity cancer.
Leiser Y; Shilo D; Abu El Naaj I; Rachmiel A
In Vivo; 2014; 28(5):769-77. PubMed ID: 25189888
[TBL] [Abstract][Full Text] [Related]
18. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.
Rohloff J; Zinke J; Schoppmeyer K; Tannapfel A; Witzigmann H; Mössner J; Wittekind C; Caca K
Br J Cancer; 2002 Apr; 86(8):1270-5. PubMed ID: 11953884
[TBL] [Abstract][Full Text] [Related]
19. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
20. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
